Patterns of Prescribing and Monitoring of Palbociclib

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 3, 2015

Primary Completion Date

December 30, 2016

Study Completion Date

December 30, 2016

Conditions

Metastatic Breast CancerAdvanced Breast CancerEstrogen Receptor-positive Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast

Interventions

DRUG

Palbociclib

Observe patients receiving palbociclib for dose adjustment and lab monitoring

All Listed Sponsors

lead

Rush University Medical Center

OTHER

NCT03285568 - Patterns of Prescribing and Monitoring of Palbociclib | Biotech Hunter | Biotech Hunter